GGrantIndex
← Leaderboards

Katharine A. Rendle

University Of Pennsylvania

$6,363,412
Attributed
$8,660,172
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.7M · FY202225
$5M$3.8M$2.5M$1.3M$0
'22
'23
'24
'25

Funding mix

By agency

NIH$13,152,776 · 7

By mechanism

P50$7,116,985 · 4
U01$3,000,303 · 1
UG3$1,593,217 · 1
R01$1,442,271 · 1

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Other Rising Stars on “Innovation

Research focus

InnovationDesignEffectivenessScreeningCancer CareRecommendationEvidence BaseBehavioral EconomicsTrial DesignCommunicationSequential Multiple Assignment Randomized TrialCaringEvaluationMalignant Neoplasm Of LungPennsylvaniaPragmatic TrialEnsureClinical CareLung Cancer ScreeningAmericanCare DeliveryCompare EffectivenessInterviewScience

Grant awards (23)

Increasing Lung cancer screening Effectiveness and Access through Regional Networks (I-LEARN)$1,593,217
UG3 · FY2025 · CA · contact PI
Penn Telehealth Research Center of Excellence in Cancer Care$1,136,977
P50 · FY2025 · CA · contact PI
Thibang Diphatlha: Testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana$687,191
U01 · FY2025 · CA
Research and Methods Core$394,974
P50 · FY2025 · CA · contact PI
Admin_Core$358,926
P50 · FY2025 · CA · contact PI
De-Implementation of Low-Value Cervical Cancer Screening$353,134
R01 · FY2025 · CA · contact PI
Pragmatic Trial$179,205
P50 · FY2025 · CA · contact PI
Advancing cancer care and equity through telehealth, communication science, and behavioral economics$1,080,625
P50 · FY2024 · CA · contact PI
Thibang Diphatlha: Testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana$689,501
U01 · FY2024 · CA
Research and Methods Core$383,130
P50 · FY2024 · CA · contact PI
De-Implementation of Low-Value Cervical Cancer Screening$353,134
R01 · FY2024 · CA · contact PI
Pragmatic Trial$174,952
P50 · FY2024 · CA · contact PI
Advancing cancer care and equity through telehealth, communication science, and behavioral economics$1,137,502
P50 · FY2023 · CA
Thibang Diphatlha: Testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana$694,021
U01 · FY2023 · CA
Research and Methods Core$395,524
P50 · FY2023 · CA · contact PI
De-Implementation of Low-Value Cervical Cancer Screening$364,284
R01 · FY2023 · CA · contact PI
Thibang Diphatlha: Testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana$219,374
U01 · FY2023 · CA
Pragmatic Trial$193,646
P50 · FY2023 · CA · contact PI
Advancing cancer care and equity through telehealth, communication science, and behavioral economics$1,137,500
P50 · FY2022 · CA
Thibang Diphatlha: Testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana$710,216
U01 · FY2022 · CA
De-Implementation of Low-Value Cervical Cancer Screening$371,719
R01 · FY2022 · CA · contact PI
Research and Methods Core$346,809
P50 · FY2022 · CA · contact PI
Pragmatic Trial$197,215
P50 · FY2022 · CA · contact PI